Visual Function for Driving in Diabetic Macular Edema and Retinal Vein Occlusion Post-Stabilization with Anti-Vascular Endothelial Growth Factor

por Nixon, Donald R, Flinn, Nicholas
Publicado 2021

Evaluation of contrast sensitivity and other visual function outcomes in neovascular age-related macular degeneration patients after treatment switch to aflibercept from ranibizuma...

por Nixon, Donald R, Flinn, Nicholas AP
Publicado 2017

Evaluation of contrast sensitivity and other visual function outcomes in diabetic macular edema patients following treatment switch to aflibercept from ranibizumab

por Nixon, Donald R, Flinn, Nicholas AP
Publicado 2018

Contrast Sensitivity Changes in Center Involving Diabetic Macular Edema Treated with Aflibercept

por Nixon, Donald R, Flinn, Nicholas, Enderlein, Claudia
Publicado 2021

Twelve-week, randomized, multicenter study comparing a fixed combination of brimonidine-timolol with timolol as therapy adjunctive to latanoprost

por Fechtner, Robert D, Harasymowycz, Paul, Nixon, Donald R, Vold, Steven D, Zaman, Fiaz, Williams, Julia M, Hollander, David A
Publicado 2011

An observational study of bimatoprost 0.01% in treatment-naïve patients with primary open angle glaucoma or ocular hypertension: the CLEAR trial

por Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Crichton, Andrew C, Discepola, Marino, Hutnik, Cindy ML, Yan, David B
Publicado 2012

An observational study of bimatoprost 0.01% in patients on prior intraocular pressure-lowering therapy: the Canadian Lumigan(®) RC Early Analysis Review (CLEAR) trial

por Crichton, Andrew C, Nixon, Donald R, Simonyi, Susan, Bhogal, Meetu, Sigouin, Christopher S, Discepola, Marino J, Hutnik, Cindy ML, Baptiste, Darryl C, Yan, David B
Publicado 2014